Zimmer Biomet
Preis: 87.14Unternehmen und Geschäftsmodell
Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in the design, manufacture, and marketing of orthopedic products. Its core offerings include joint reconstruction, spinal surgery, dental implants, and surgical instruments. The company operates primarily in the orthopedic and dental segments, with major revenue sources stemming from joint replacement and surgical solutions. Zimmer Biomet serves hospitals, outpatient surgery centers, and dental practices worldwide, focusing on improving patient outcomes through innovative technologies and solutions.
Anlageprofil
Zimmer Biomet presents a balanced investment profile, appealing to investors seeking moderate growth and income through dividends. The company has a stable dividend yield, indicating a commitment to returning value to shareholders. Its recent revenue growth suggests potential for capital appreciation, while the moderate risk level may attract those with a balanced investment strategy.
Fundamentale Kennzahlen (experimentell)
- EPS (TTM) — Gewinn pro Aktie der letzten 12 Monate, $
- 3.87 OK
- Umsatz QoQ — Umsatzwachstum im Quartalsvergleich
- -7.0% ↓
- EPS-Überraschung
- 1.7% entspricht den Erwartungen
- 20d Volatilität
- 1.3% stabil
- Dividendenrendite
- 1.3% moderat letzter Ex-Tag: 2026-03-31
Im Portfolio verfolgen
Preischart
| Datum | Vorher | Nachher | Grund |
|---|---|---|---|
| 2026-06-09 02:56 | Verkaufen | Halten | Mixed performance and fundamentals indicate caution. |
| 2026-05-30 02:55 | Halten | Verkaufen | Weak momentum and high risk; cautious approach advised. |
| 2026-05-08 15:20 | — | Halten | Weak momentum and mixed fundamentals suggest caution. |
| Datum | Analyst | Action | Ziel | Preis damals |
|---|---|---|---|---|
| 2026-04-29 13:52 | Truist Financial | Ziel gesenkt | 98 → 92 | 80.8 |
| 2026-04-29 11:31 | Canaccord Genuity | Ziel gesenkt | 93 → 83 | 82.8 |
| 2026-04-29 11:21 | Stifel Nicolaus | Ziel gesenkt | 110 → 105 | 82.8 |
Noch nichts